港股异动 | 汇量科技(1860.HK)大涨超11% 获多家机构看好
格隆汇6月10日丨汇量科技(1860.HK)现报9.01港元,大涨11.37%,暂成交9637万港元,最新市值144亿港元。瑞银最新发研报指,市场低估了汇量科技旗下平台Mintegral于2021至2022年度潜在增长趋势,且公司于第二及三季盈利有望获重新评级,因此重申其“买入”评级。该行对Mintegral长线前景感到乐观,相信受惠于游戏内广告行业的增长,维持其今年度每股盈利预测,但上调明年盈测8%,目标价由9.5港元升至12.5港元。招银国际亦指,作为全球领先的移动广告分析平台,汇量科技有望受益于应用程序全球化和SaaS发展带来的蓬勃广告需求;给予公司买入评级,基于DCF的目标价为11.1港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.